跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
BYOOVIZ 10 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
BYOOVIZ 10 MG/ML SOLUCION INYECTABLE
Samsung Bioepis Nl B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 7, 2023
Approval ID
83c22fe1e8dd8a0b
Company
Samsung Bioepis Nl B.V.
Type
Standard
Approval Details
Approval Id
83c22fe1e8dd8a0b
Drug Cima Aemps Name
BYOOVIZ 10 MG/ML SOLUCION INYECTABLE
Register Number
1211572001
Holder Company Name
Samsung Bioepis Nl B.V.
Marketing Company Name
Samsung Bioepis Nl B.V.
Holder Company Detail Path
/organization/samsung-bioepis-nl-b-v
Marketing Company Detail Path
/organization/samsung-bioepis-nl-b-v
Authorization Date
2023-03-07
Dosage Form
SOLUCIÓN INYECTABLE
Dose
10 MG/ML
Route Of Administration
VÍA INTRAVÍTREA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Samsung Bioepis Nl B.V.
Company Detail Path
/organization/samsung-bioepis-nl-b-v
Company Information
Pharmaceutical Company Name
Samsung Bioepis NL B.V.
Country Name
Netherlands
Active Ingredients
RANIBIZUMAB
2,3 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 7, 2023
Approval ID
83c22fe1e8dd8a0b
Type
Standard
Back to CIMA-AEMPS Approvals
BYOOVIZ 10 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details